Liensinine inhibits IL-1β-stimulated inflammatory response in chondrocytes and attenuates papain-induced osteoarthritis in rats
International Immunopharmacology · 2024-09 · 138 · 112601
DOI: 10.1016/j.intimp.2024.112601 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024-09. Verfasst von Lei Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang 453003, Henan, China; Clinical Medical Center of Tissue Engineering and Regene…. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Chondrocytes, Interleukin-1beta, NF-kappa B. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Education Department of Henan Province, Xinxiang Medical University, Department of Science and Technology of Henan Province.
Abstract (Originalsprache)
Osteoarthritis (OA) is a joint disease caused by inflammation of cartilage and synovial tissue. Suppressing the process of inflammatory reaction and the generation of oxidative stress is an effective strategy to alleviate the progression of OA. Liensinine is one of the main components of lotus seeds, which has anti-hypertensive and anti-arrhythmia activities. In this study, we aimed to determine the anti-inflammatory effect of liensinine in an OA. Here, we found that liensinine significantly inhibited the inflammatory response of SW1353 cells and primary chondrocytes by inhibiting the release of inflammatory cytokines and oxidative stress. Moreover, we showed that liensinine was able to inhibit the activation of the NF-κB signaling pathway in IL-1β-induced SW1353 cells. Lastly, we found that liensinine significantly ameliorated cartilage damage and inflammatory response in papain-induced rats. Our study demonstrated a significant protective effect of liensinine against OA, which might be by inhibiting the activation of the NF-κB signaling pathway, and provide a new insight for the treatment of OA using liensinine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang 453003, Henan, China; Clinical Medical Center of Tissue Engineering and Regeneration, Xinxiang Medical University, Xinxiang 453003, Henan, China; Xi…
- Xinxiang Key Laboratory of Cellular Stress Biology, School of Life Sciences and Technology, Xinxiang Medical University, Xinxiang 453003, Henan, China.
- Institutes of Health Central Plains, Xinxiang Medical University, Xinxiang 453003, Henan, China.
- The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang 453003, Henan, China; Xinxiang Key Laboratory of Cellular Stress Biology, School of Life Sciences and Technology, Xinxiang Medical University, Xinxi…
- The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang 453003, Henan, China; Clinical Medical Center of Tissue Engineering and Regeneration, Xinxiang Medical University, Xinxiang 453003, Henan, China. El…
Förderung
- Education Department of Henan Province
- Xinxiang Medical University
- Department of Science and Technology of Henan Province
- Science and Technology Innovation Talents in Universities of Henan Province
- Key Research and Development Program of Jiangxi Province
Zitieren
APA
Wang, L., Shao, T., Liu, C., Han, Z., Zhang, S., Dong, Y., Han, T., Cheng, B., & Ren, W. (2024). Liensinine inhibits IL-1β-stimulated inflammatory response in chondrocytes and attenuates papain-induced osteoarthritis in rats. International Immunopharmacology, 138, 112601. https://doi.org/10.1016/j.intimp.2024.112601
Vancouver
Wang L, Shao T, Liu C, Han Z, Zhang S, Dong Y, et al. Liensinine inhibits IL-1β-stimulated inflammatory response in chondrocytes and attenuates papain-induced osteoarthritis in rats. International Immunopharmacology. 2024;138:112601. doi:10.1016/j.intimp.2024.112601
BibTeX
@article{Wang2024,
author = {Wang, Lei and Shao, Tianci and Liu, Chen and Han, Ziyu and Zhang, Shenghui and Dong, Yuqian and Han, Tao and Cheng, Binfeng and Ren, Wenjie},
title = {Liensinine inhibits IL-1β-stimulated inflammatory response in chondrocytes and attenuates papain-induced osteoarthritis in rats},
journal = {International Immunopharmacology},
year = {2024},
volume = {138},
pages = {112601},
doi = {10.1016/j.intimp.2024.112601}
}
EUVIMED